MTOR and hepatocellular carcinoma: Proteins of the PI3K/AKT/mTOR signaling pathway are significantly raised in PET/CT-positive HCC patients, indicating that activation of this pathway might be a key factor of the glycolytic phenotype in HCC cells [12].